Orchid Pharma's newly-formed antimicrobial solutions division is targeting a turnover of up to Rs 300 crore in the next three ...

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, has embarked on its ...

The Nifty Pharma has gained around 37% year to date. The growth continues to be led by the US sales and well supported by ...

The SBTi has validated and approved India's Piramal Pharma’s near-term greenhouse gas (GHG) emission reduction targets.

Lupin has announced a non-exclusive patent licence agreement with Takeda for the commercialisation of Vonoprazan Tablets in ...

The company is involved in the manufacturing and global marketing of a diverse range of pharmaceuticals both in India and internationally. Dr. Reddy’s Labs recently acquired MenoLabs from Amyris ...

The Indian biotechnology sector is a rapidly advancing segment within the economy, often referred to as a sunrise sector due ...

On September 3, the pharmaceutical company conducted a press conference to announced that it has received final approval from ...

Lupin Limited partners with Takeda to launch Vonoprazan tablets in India, targeting acid peptic disorders with Lupivon brand.

DCGI suspends Entod Pharma`s eye drop permission for presbyopia treatment due to unapproved claims. The company will ...

India faces a rising concern as diabetes increasingly links to neurodegenerative diseases like dementia and Alzheimer’s. With ...

Elara Capital said that organic growth will be in the range of 11-14 per cent for pharma stocks but will fall short of our ...